Haemonetics Corporation 8-K Summary
Business Context and Reporting Period
Haemonetics Corporation (HAE) filed a Current Report on Form 8-K on February 5, 2026. The filing announces financial results for the third quarter and the nine months ended December 27, 2025.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. The filing text does not provide a clear value for these metrics.
Material Changes
No material changes versus prior periods are detailed in the provided text, as the specific financial comparisons are contained within the referenced press release.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings. No specific guidance, outlook, or risk factors are detailed in this excerpt.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 and nine-month 2025 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2025 guidance or forward-looking statements in the press release.
- Confirm the exact fiscal period end date (December 27, 2025) for accurate period comparisons.